Efficacy and safety of sofosbuvir-based therapies in patients with advanced liver disease in a real-life cohort

BACKGROUND: The combination of sofosbuvir (SOF) with ribavirin (RBV) or daclatasvir (DCV) or simeprevir (SIM) for the treatment of patients infected by chronic hepatitis C (CHC) have led to significantly increased rates of sustained virological response (SVR). However, there is only limited data reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Kutala, Blaise K, Mouri, Feryel, Castelnau, Corinne, Bouton, Valerie, Giuily, Nathalie, Boyer, Nathalie, Asselah, Tarik, Marcellin, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739107/
https://www.ncbi.nlm.nih.gov/pubmed/29296102
http://dx.doi.org/10.2147/HMER.S149578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739107/
https://www.ncbi.nlm.nih.gov/pubmed/29296102
http://dx.doi.org/10.2147/HMER.S149578

Ejemplares similares